CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
Alcohol +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03521817
NCT03521817N/ACompleted

The Effects of Alcohol Consumption on Central Adiposity and Testosterone Following Weight Loss in Obese, Pre-menopausal Women

Pennington Biomedical Research Center·interventional·Posted May 11, 2018·Updated Jun 17, 2020

In Brief

A clinical study evaluating Alcohol and No Alcohol for Alcohol Drinking and 4 related conditions. Completed, enrolled 12 participants across 1 site.

Detailed Summary

The objective of the proposed study is to enroll women with obesity that will undergo a controlled, energy restricted feeding intervention to test the effects of chronic ethanol consumption on adipose distribution and circulating testosterone during weight loss.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMay 11, 2018
Enrollment StartMay 18, 2018
Primary CompletionNov 4, 2019
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 8.1 years ago

Interventions

Alcoholother

The ethanol group will consume a 30% energy restriction diet that will also include \~2.5 standard drinks, or 35 grams of ethanol, administered as 80-proof distilled spirits (e.g. 80 proof gin, rum, vodka, whiskey, or tequila). In the United States, one "standard" drink contains roughly 14 grams of pure alcohol.

No Alcoholother

This group will not consume alcohol. Thus 0 kcal/d will come from alcohol